Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 4.9%

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) fell 4.9% during trading on Monday . The company traded as low as $15.01 and last traded at $15.06. 209,613 shares were traded during trading, a decline of 27% from the average session volume of 285,469 shares. The stock had previously closed at $15.83. Analyst Ratings Changes […]

Related Keywords

Canada ,Cyrus Harmon ,Nasdaq ,News Ratings For Olema Pharmaceuticals Daily ,Jpmorgan Chase Co ,Olema Pharmaceuticals Company Profile ,Olema Pharmaceuticals Inc ,Acadian Asset Management ,Olema Pharmaceuticals ,Hedge Funds Weigh In On Olema Pharmaceuticals ,Credit Suisse Group ,Ep Wealth Advisors ,Royal Bank ,Olema Pharmaceuticals Stock Performance ,Get Free Report ,Suisse Group ,Director Cyrus Harmon ,Director Bvf Partners ,Asset Management ,Olema Pharmaceuticals Daily ,Nasdaq Olma ,Dolma ,Medical ,Stocks ,Technicals ,